Skip to main content
Clinical Trials/NCT04462146
NCT04462146
Unknown
N/A

Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD): An Open Clinical Trial

Universitat Jaume I1 site in 1 country24 target enrollmentFebruary 1, 2021

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prolonged Grief Disorder
Sponsor
Universitat Jaume I
Enrollment
24
Locations
1
Primary Endpoint
Change in the Inventory of Complicated Grief (ICG) validated in the Spanish population
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to investigate the feasibility, acceptability and preliminary efficacy of an internet delivered cognitive behavior treatment (ICBT) for people with prolonged grief disorder (PGD) compared to a face-to-face intervention for PGD.

Detailed Description

Grief is an intense emotional reaction to the loss of a loved one. It produces feelings of regret and longing that usually decrease over time. However, some people have difficulty adapting to the loss and develop Prolonged Grief Disorder (PGD). An open clinical trial will be conducted to investigate the feasibility \[initial efficacy and acceptability\] of an Internet delivered cognitive behavior treatment (ICBT) for adult people diagnosed with prolonged grief disorder (PGD). There will be at least 24 participants that will be randomly assigned to experimental group (internet-based treatment for PGD) or active control group (traditional face- to-face intervention for PGD). Four assessment moments will be included (pre-treatment, post-treatment, 3 months follow-up and 12 months follow-up). The present study aims to improve knowledge about the feasibility, acceptability and preliminary efficacy of an ICBT for PGD and conduct a preliminary comparison between two intervention conditions (internet-based intervention vs. traditional face-to-face intervention). Also, the investigators aim to collect information that can help to improve the efficacy and acceptability of Internet-based interventions in general.

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
June 30, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Universitat Jaume I
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age ≥ 18 years
  • Meeting diagnostic criteria for PGD
  • Sign an informed consent
  • Ability to understand and read Spanish
  • Ability to use a computer and having access to the Internet
  • Having an e-mail address

Exclusion Criteria

  • Presence of risk of suicide or self-destructive behaviors
  • Presence of another severe mental disorder (substance abuse or dependence, psychotic disorder, dementia o bipolar disorder)
  • Presence of severe personality disorder
  • Presence of a medical condition whose severity or characteristics prevent the performance of treatment
  • Receiving other psychological treatment during the study for PGD
  • An increase and/or change in the medication during the study period

Outcomes

Primary Outcomes

Change in the Inventory of Complicated Grief (ICG) validated in the Spanish population

Time Frame: immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment

It is a self-applied instrument that assesses grief symptoms in adults. Good psychometric properties; cronbach's alpha of0.94 in the original version and 0.88 in the Spanish adaptation. It consists of 19 items with five response categories (Likert): 0; never 1; rarely 2; sometimes 3; often and 4; forever. The items value the frequency of the symptom explored (emotional, cognitive or behavioral). It is completed in approximately 10 minutes. The total score is calculated by adding the score of the 19 items. The total score ranges from 0 to 76, with highest scores corresponding to a greater probability of suffering complicated grief.

Change in the Beck Depression Inventory - Second Edition validated in the Spanish population

Time Frame: immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment

It is a self-applied instrument that assesses characteristic attitudes and symptoms of depression. Psychometric properties; Cronbach's alpha of 0.76 to 0.95 and test-retest reliability of around 0.8. It consists of 21 items that are scored on a scale from 0 to 3. It is calculated by adding the score of the 21 items and the maximum total score is 63.

Secondary Outcomes

  • Change in the Overall Depression Severity and Impairment Scale (ODSIS) validated in the Spanish population(immediately pre-treatment, weekly during treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in the Work and Social Adjustment Scale (WSAS) validated in Spanish language(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in the Positive and Negative Affect Schedule (PANAS) validated in the Spanish population(immediately pre-treatment, weekly during treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in Purpose-In-Life Test (PIL- 10)(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in the Overall Anxiety Severity and Impairment Scale (OASIS) validated in the Spanish population(immediately pre-treatment, weekly during treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in the Quality of Life Index (QLI) validated in Spanish language(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in the Posttraumatic Growth Inventory (PTGI) validated in Spanish language(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in Typical Beliefs Questionnaire (TBQ)(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in Five-Facet Mindfulness Questionnaire (FFMQ-15) validated in Spanish population(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)
  • Change in Self-Compassion Scale Short Form (SCS-SF) validated in Spanish population(immediately pre-treatment, immediately post-treatment, 3-month post-treatment, 12-month post-treatment)

Study Sites (1)

Loading locations...

Similar Trials